Ashwagandha and Antidepressants: Documented Interactions
Ashwagandha (Withania somnifera) has become one of the most popular adaptogenic herbs, with a long traditional use in Ayurveda. Many people exploring it are already taking prescription antidepressants, which raises a common question: what is documented about combining them? In this guide, we walk through the evidence on potential interactions, flag which combinations call for extra caution, cover reported liver injury and thyroid effects, and give you practical talking points for your next conversation with your healthcare provider.
Key Takeaways
- ✓Clinical data on ashwagandha with SSRIs are limited. A lack of published reports does not show that the combination is free of risk.
- ✓The combination may produce additive sedation, particularly with tricyclic antidepressants and trazodone.
- ✓Ashwagandha may raise thyroid hormone levels, which is relevant if you take levothyroxine or have an overactive thyroid.
- ✓Cases of liver injury, some severe, have been reported with ashwagandha. Denmark banned it in food supplements in 2023.
- ✓The MAOI combination is generally considered contraindicated in clinical literature due to theoretical serotonergic (affecting serotonin levels) risk.
- ✓Many healthcare providers prefer to be informed about all supplements their patients are taking, including ashwagandha, especially alongside an antidepressant regimen.
1. What Is Ashwagandha and How Does It Work?
Ashwagandha has been part of Ayurvedic medicine for thousands of years, where it is classified as a rasayana, a tonic. In pharmacological terms, its primary active compounds arewithanolides (the main active compounds that give ashwagandha its effects), a group of steroidal lactones that influence several biological pathways related to stress and mood.
The mechanisms most relevant to antidepressant interactions include:
- Stress-hormone (HPA axis) effects. Ashwagandha has been studied for effects on the hypothalamic-pituitary-adrenal axis, including cortisol.
- GABAergic (related to GABA, a calming brain chemical) activity. In laboratory studies, ashwagandha extracts acted on GABA-A receptors, the same receptor family targeted by benzodiazepines such as diazepam. This is the basis for concern about additive sedation.
- Serotonin modulation. Animal studies demonstrate that ashwagandha increases serotonin levels in the prefrontal cortex and hippocampus, likely through modulation of tryptophan hydroxylase activity rather than reuptake inhibition.
- Thyroid hormone effects. Ashwagandha has been reported to increase serum T3 and T4 levels, which is relevant for people taking levothyroxine or with an overactive thyroid.
These overlapping mechanisms, particularly the serotonin and GABA activity, are exactly why the question of combining ashwagandha with antidepressants deserves a closer look. Let's go through each antidepressant class one at a time.
2. Ashwagandha and SSRIs
Selective serotonin reuptake inhibitors, including sertraline, escitalopram, fluoxetine, citalopram,and paroxetine, are the most commonly prescribed antidepressant class worldwide. Data on combining them with ashwagandha are limited.
What the Evidence Shows
Published case reports of serotonin syndrome from combining ashwagandha with an SSRI are lacking. The absence of reported problems does not show that the combination is free of risk: herb-drug interactions are systematically underreported in the systems that track supplement side effects, and no controlled studies have tested the combination.
The theoretical concern centers on additive serotonin effects (where both substances increase serotonin, and the combined effect is stronger than either alone). Ashwagandha does not block serotonin reuptake the way SSRIs do. Instead, it appears to boost serotonin production through a different pathway. The result? Your overall serotonin levels could end up higher than what either one would produce on its own.
Practical Risk Assessment
The theoretical risk of serotonin syndrome (a serious condition where serotonin levels get dangerously high) is thought to go up with:
- High-dose SSRI therapy (e.g., fluoxetine 60 mg or above)
- Concurrent use of other serotonergic agents (triptans, tramadol, St. John's Wort)
- High-dose ashwagandha supplementation (above 1,000 mg daily)
- Genetic variations in the CYP2D6 enzyme that make your body slower at breaking down SSRIs
Here's where it gets important: When people do combine these with their doctor's knowledge, studies have typically started at around 300 mg daily and increased gradually. Watch for agitation, confusion, rapid heart rate, dilated pupils, or muscle twitching. These are recognized warning signs of serotonin syndrome, a condition that healthcare providers treat as a medical emergency.
3. Ashwagandha and SNRIs
Serotonin-norepinephrine reuptake inhibitors, principally venlafaxine and duloxetine, may carry a somewhat higher theoretical interaction risk than SSRIs. Why? Because they affect both serotonin and norepinephrine systems, which means more overlap with what ashwagandha does.
Ashwagandha's cortisol-lowering effects indirectly influence norepinephrine signaling, since cortisol and norepinephrine are closely linked through your body's stress response. In theory, combining them could lead to extra sedation or blood pressure changes. The combination has not been studied in clinical trials.
The sedation risk is the main practical concern here. Both SNRIs (especially when you first start them) and ashwagandha can make you drowsy. So if you are combining them for the first time, be careful with driving and anything that requires sharp focus until you know how the combination affects you.
4. Ashwagandha and Tricyclic Antidepressants
Tricyclic antidepressants (TCAs), including amitriptyline, nortriptyline, imipramine, and doxepin, present a more complex picture. TCAs are broad-acting medications that affect serotonin, norepinephrine, histamine, and acetylcholine receptors all at once. That broad activity is what gives them their significant sedation and anticholinergic side effects (dry mouth, blurred vision, constipation).
Here's the key concern: the additive sedation from ashwagandha's calming GABA effects layered on top of TCAs' antihistamine-related drowsiness. Together, they can make you much sleepier than either one alone. This combination calls for extra caution, especially for older adults or anyone taking other sedating medications.
Bottom line: If you are on a TCA and want to try ashwagandha, this is one where having your doctor in the loop is important. Clinical practice typically involves conservative dosing, and your prescriber will want to keep an eye on how sedated you are feeling overall.
5. Ashwagandha and MAOIs
Monoamine oxidase inhibitors, including phenelzine, tranylcypromine, and selegiline, have the most restrictive interaction profiles of any antidepressant class. This is the section where we need to be most careful. MAOIs work by preventing your body from breaking down serotonin, norepinephrine, and dopamine. That means anything else that raises those brain chemicals could potentially trigger a hypertensive crisis (dangerously high blood pressure) or serotonin syndrome.
Given ashwagandha's documented effects on serotonin production and its influence on stress hormone signaling, this combination is generally considered inadvisable. No case reports of adverse events exist, partly because MAOIs are rarely prescribed these days, which makes real-world data scarce. But the pharmacological reasoning for concern is strong enough that most practitioners would advise against it.
6. The Thyroid Connection
This is one that a lot of people miss. A frequently overlooked piece of the ashwagandha-antidepressant puzzle involves thyroid function. Subclinical hypothyroidism (a mildly underactive thyroid that may not cause obvious symptoms) is a known contributor to treatment-resistant depression, and many people take levothyroxine for it alongside their antidepressant.
Small clinical studies have reported rises in serum T4 and T3 with ashwagandha, including in people with subclinical hypothyroidism (Sharma et al., 2018), and thyrotoxicosis (an overactive-thyroid state) has been reported in case reports. Ashwagandha may raise thyroid hormone levels, which is relevant if you take levothyroxine or have an overactive thyroid.
For people on levothyroxine, this thyroid-boosting effect could shift hormone levels enough to require a dose adjustment. And here is the part that really matters: abrupt changes in thyroid status can destabilize your mood, potentially undermining what your antidepressant is doing or even mimicking anxiety symptoms. That can be confusing and distressing if you do not know what is causing it.
What you can do: If you are taking levothyroxine and an antidepressant and want to add ashwagandha, ask your doctor about checking your thyroid levels (TSH and free T4) before you start, and then again after six to eight weeks. That way you will catch any shifts early.
7. Reported Liver Injury
Cases of liver injury, some severe, have been reported with ashwagandha, usually weeks to months after starting. Denmark banned it in food supplements in 2023 after a risk assessment could not set a safe intake. Stop and seek care if you notice jaundice, dark urine, itching or marked fatigue.
This matters for antidepressant users too, because several antidepressants can themselves affect the liver in rare cases. Tell your prescriber if you take ashwagandha, especially if you have liver disease or drink alcohol regularly.
8. Dosage Considerations
If you and your healthcare provider decide the combination makes sense for you, here are some practical ways to minimize risk:
- Start low. Standard supplemental doses reported in the literature range from 300 to 600 mg of a standardized root extract (typically standardized to 5% withanolides), with many studies beginning at the lower end of this range.
- Avoid escalation without guidance. Some practitioners advise against increasing ashwagandha dosage without consulting a prescriber, particularly when adjusting antidepressant doses simultaneously.
- Watch for warning signs. Unusual agitation, excessive drowsiness, mood changes, or signs of liver injury (jaundice, dark urine, itching, marked fatigue) are reasons to stop and seek advice. Liver injury has been reported weeks to months after starting.
- Choose reputable products. Contamination and mislabeling are common in the supplement industry. Third-party tested products reduce this risk.
9. When to Avoid the Combination Entirely
There are some situations where combining ashwagandha and antidepressants is generally considered a no-go:
- You are taking an MAOI or have discontinued one within the past 14 days
- You are taking multiple serotonergic medications (e.g., an SSRI plus a triptan or tramadol)
- You have a history of serotonin syndrome
- You have hyperthyroidism or Graves' disease
- You have liver disease or have had liver injury from a medicine or supplement
- You are pregnant or breastfeeding (no safety data; several EU authorities advise against use).
- You are scheduled for surgery within two weeks (ashwagandha may potentiate anesthetic sedation)
10. How to Discuss Ashwagandha With Your Doctor
We get it. A lot of people hesitate to bring up supplements with their doctor, sometimes because they worry about being dismissed. But an honest conversation is essential for your safety, and most providers genuinely want to know. Here are a few ways to make that conversation easier:
- Frame it clinically. Rather than asking “is ashwagandha okay?”, try: “I've been reading about ashwagandha's effects on cortisol and GABAergic activity. Given my current medication regimen, are there any pharmacological concerns with adding it?”
- Bring the product label. Your prescriber needs to know the specific extract type, dose, and standardization, since not all ashwagandha products are equivalent.
- Ask about monitoring. Ask whether liver or thyroid tests make sense for you, and agree when to check in.
Sources & Further Reading
- Candelario M, et al. "Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABA-A and GABA-rho receptors." J Ethnopharmacol. 2015;171:264-272.
- Sharma AK, Basu I, Singh S. "Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients." J Altern Complement Med. 2018;24(3):243-248.
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. "Ashwagandha." National Institute of Diabetes and Digestive and Kidney Diseases.
- Danish Veterinary and Food Administration (Fødevarestyrelsen). Ban on ashwagandha in food supplements, following a risk assessment by DTU National Food Institute. 2023.
- Natural Medicines Comprehensive Database. "Ashwagandha Monograph." Therapeutic Research Center.
This article synthesizes findings from peer-reviewed research, pharmacological databases, and clinical monographs. It is intended for educational purposes and does not constitute medical advice.
Check your specific combination
Enter your antidepressant and any supplements you're considering into our free Interaction Reference.
Open Interaction Reference